Skip to content

Clinical trials

Phase 3 Hypertension, Pulmonary trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Phase: Phase 3 Country / region: Japan Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20082
20094
20104
20121
20131
20141
20151
20161
20171
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated5
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer6
Biogen2
Eli Lilly and Company2
GlaxoSmithKline2
Insmed Incorporated2
Novartis Pharmaceuticals2
Pfizer2
Mallinckrodt1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary20
Pulmonary Arterial Hypertension10
Lung Diseases, Interstitial2
Familial Primary Pulmonary Hypertension1
Respiratory Aspiration1
Ventricular Dysfunction, Left1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.